Skip to content
healthcare.dev

TOPIRAMATE

NDC 31722-549, Topiramate, capsule, extended release, from Camber Pharmaceuticals, Inc..

Product NDC
31722-549
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217443
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-549 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE100 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
31722-549-303172205493030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-549-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dbc52b16-b93d-4d83-942b-485c502db1fa

Use it

Look up 31722-549 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-549 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-549. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.